Actinogen Medical Ltd (ACW)

Sydney
0.115
0.000(0.00%)
  • Volume:
    1,797,606
  • Bid/Ask:
    0.115/0.120
  • Day's Range:
    0.115 - 0.120

ACW Overview

Prev. Close
0.115
Day's Range
0.115-0.12
Revenue
30K
Open
0.115
52 wk Range
0.019-0.195
EPS
0
Volume
1,797,606
Market Cap
192.33M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
4,611,699
P/E Ratio
-
Beta
1.15
1-Year Change
422.73%
Shares Outstanding
1,672,458,547
Next Earnings Date
21 Feb 2022
What is your sentiment on Actinogen Medical Ltd?
or
Market is currently closed. Voting is open during market hours.

Actinogen Medical Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralNeutralStrong BuyBuy
Technical IndicatorsSellSellSellStrong BuyStrong Buy
SummarySellNeutralNeutralStrong BuyStrong Buy

Actinogen Medical Ltd Company Profile

Actinogen Medical Ltd Company Profile

Employees
0
Market
Australia

Actinogen Medical Limited is an Australia-based biotechnology company. The Company is engaged in developing treatment for cognitive impairment associated with neurological diseases of raised cortisol levels inside brain cells. The Company's lead drug candidate, Xanamem, has been designed to block the production of cortisol the stress hormone in the brain. Xanamem is a unique inhibitor of the 11β-HSD1 enzyme that achieves target engagement in the central nervous system. It is an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Chronically elevated cortisol is associated with cognitive decline in Alzheimer’s Disease, linked to cognitive impairment and anxiety in Fragile X syndrome, and cognitive impairment in neuropsychiatric diseases. The Company focuses on developing Phase II clinical trial evaluating Xanamem in the treatment of cognitive impairment associated with Alzheimer’s disease.

Read More
  • will it keep going?
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.